Veritas In Silico’s Strategic Shift to Specialty Pharma
Veritas In Silico Inc. (JP:130A) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Veritas In Silico Inc. is focused on expanding its platform business for mRNA-targeted drug discovery through strategic contracts and in-house pipeline creation. The company aims to enhance shareholder value by transitioning into a specialty pharmaceutical company with a balanced approach of revenue generation and investment.
For further insights into JP:130A stock, check out TipRanks’ Stock Analysis page.
Trending Articles
TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know who to trust when making investment decisions.